1/1
2 files

Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan

figure
posted on 14.04.2020 by Takashi Kadowaki, Masakazu Haneda, Hiroshi Ito, Kazuyo Sasaki, Yuka Yamada

The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

Exports